Generate a tailored SOP for Dr. Bernadette Fitzgibbon. Improve your application with a focused, well-structured draft.
Bernadette Fitzgibbon is an Associate Professor and neuroscientist at the Australian National University with decades of experience in clinical trials research focusing on mental health and chronic pain. She currently serves as the Director of Psychiatry Research at Paratus Clinical. Her research program includes the optimization of brain stimulation and psychedelic therapies, overseeing large multi-site intervention trials both in Australia and abroad. She has developed meaningful collaborations with consumers, volunteers, policymakers, and service providers to ensure that the outcomes of her work contribute to real-world clinical impact. With more than 80 published journal articles and three book chapters, she has been awarded over five million dollars in research funding. Her contributions have been recognized with multiple awards, including delivering the 2021 Tess Cramond Lecture at the Australasian Pain Society Meeting and receiving the Australasian Brain Stimulation Society Early Career Award in 2018. Bernadette has presented her work at over 70 conferences, including plenary sessions at the Neuromodulation Society Australia & New Zealand 15th Annual Scientific Meeting. Her passion for advancing brain sciences in Australia is evident through her role as chair of the Australian Brain Alliance EMCR Network from 2017 to 2021 and as an Executive Member of the Australian Brain Alliance and the Australasian Brain Stimulation Society.
Australian National University • Canberra, Australia
Leads research in psychiatry and mental health.
Requirements are standardized across most Master of Science and Arts programs within the College of Science and College of Arts & Social Sciences.